List of redirects
Jump to navigation
Jump to search
Showing below up to 50 results in range #8,941 to #8,990.
- CDRH → Center for Devices and Radiological Health
- CDT → Deep vein thrombosis invasive therapy
- CD 1a → Group 1 CD1
- CD infection → Clostridium difficile infection
- CED → Camurati-Engelmann disease
- CEDARS → Comprehensive Evaluation Of Defibrillators And Resuscitative Shock
- CEEV → Tick-borne encephalitis
- CEF regimen → FEC regimen
- CELL → Cost Effectiveness Of Lipid Lowering Study
- CELLO → Barrett's esophagus
- CEOS → Congenital Esotropia Observational Study
- CEP → Cep
- CERCLA → Superfund
- CES → CES (Disambiguation page)
- CETP → Cholesterylester transfer protein
- CETP Inhibitors → Torcetrapib
- CEV → California encephalitis virus
- CE virus → California encephalitis virus
- CF → Cystic fibrosis
- CFA → Craniofacial anomalies
- CFC → Cardiofaciocutaneous syndrome
- CFR → Coronary flow reserve
- CFS → Chronic fatigue syndrome
- CFTR → Cystic fibrosis transmembrane conductance regulator
- CFTR gene → CFTR (gene)
- CF Vite → Multivitamin
- CGD → Chronic granulomatous disease
- CGG trinucleotide repeat → Trinucleotide repeat disorder
- CGH → Comparative genomic hybridization
- CGMP → Cyclic guanosine monophosphate
- CGPM → General Conference on Weights and Measures
- CGRP → Calcitonin gene-related peptide
- CGS → Centimetre gram second system of units
- CHA2-DS2-VASc score → CHA2DS2-VASc Score
- CHA2DS2-VASC → CHA2DS2-VASc Score
- CHA2DS2-VASc score → CHA2DS2-VASc Score
- CHADS → CHADS Score
- CHADS2 → CHADS Score
- CHADS2 Score → CHADS Score
- CHADS Score → CHADS2 score
- CHADS score → CHADS2 score
- CHADs Score → CHADS2 score
- CHAMPIONS → Controlled High-Risk Subjects Avonex Ms Prevention In Ongoing Neurologic Surveillance
- CHAMPS → Controlled High-Risk Subjects Avonex Ms Prevention Study
- CHAPSO → CHAPS detergent
- CHARGE Association → CHARGE syndrome
- CHARISMA → Clopidogrel For High Atherothrombotic Risk, Ischemic Stabilization, Management, And Avoidance
- CHARM → Candesartan Cilexitil (Atacand) In Heart Failure Assessment Of Reduction Mortality And Morbidity
- CHARM Added Trial → Candesartan In Heart Failure—Added Trial
- CHARM Alternative Trial → Candesartan In Heart Failure—Alternative Trial